Thu, Nov 21, 2024
The Foreign Portfolio Investors (FPIs) ownership in companies listed on the National Stock Exchange (NSE) has been steadily declining over the past three years but still they are the major shareholder.
More >
Morgan Stanley maintains cautious optimism on the chemical sector, favouring Deepak Nitrite for its resilience while highlighting muted demand and pricing pressures impacting near-term earnings across key players.
Tue, Nov 19, 2024
Year-to-date, Suzlon’s stock has rallied 62 per cent and has delivered multibagger returns of 670 per cent over the last two years.
Mon, Nov 18, 2024
Muthoot Finance's stock has recovered a large part of its losses from earlier in November and is up by 31 percent year-to-date. Rural India remains a key growth driver, contributing nearly two-thirds of the gold stock held at Muthoot’s extensive branch network.
Sun, Nov 17, 2024
Stocks to buy: Check out five stocks recommended by Motilal Oswal with growth potential, along with their target prices.
Tata Group Stocks: Brokerages identify five Tata Group stocks with good returns. These stocks are gaining attention from analysts and investors as they are backed by strong fundamentals and growth prospects. Take a look.
Thu, Nov 14, 2024
Suzlon Energy shares rally 5% on robust order win, reversing downtrend
Tue, Nov 12, 2024
UPL Ltd gains 7% despite pricing pressures; reports Q2 revenue growth of 4%
The company’s performance was further hindered by a 45 per cent year-on-year increase in employee costs, which analysts noted as a one-off but substantial impact.
The consolidated revenue of the company for the year ended December 2023 stood at approximately $96 million.
Wed, Nov 06, 2024
Solar power stock Waaree Energies sees a seven-day rally, reaching an intraday high of Rs 3,743 as market cap climbs to over Rs 1 lakh cr
Mankind Pharma, one of India’s largest pharmaceutical players, witnessed its shares surge by 6 per cent to a peak of Rs 2,882.75 on the BSE after announcing a robust 29 per cent year-on-year profit growth for the quarter ending September 2024.
Tue, Nov 05, 2024
Revenue saw a significant boost as well, soaring 122 per cent to Rs 1,044.7 crore from Rs 470 crore in the same period last year.
Tue, Oct 29, 2024
Nifty staged a solid recovery towards the 24,500 mark, led by a strong midcap rally and PSU bank gains. Metals surged on potential Chinese stimulus, while auto, FMCG, IT, and pharma sectors stayed under pressure.
Indian markets stabilized by midday, supported by gains in financials, while ongoing FII selling and weak performance in auto and IT sectors weighed on sentiment.
Mon, Oct 28, 2024
Despite the prevailing foreign investor outflows and the resulting market correction, these stocks show promise for Diwali investors looking to capture significant returns.
Fri, Oct 25, 2024
Key drivers included better asset quality, with gross NPAs reduced to 1.24 per cent from 1.35 per cent last quarter and 1.78 per cent in the same period last year.
Key sectors facing heavy selling included Nifty Auto, Energy, Infrastructure, Media, Realty, PSU Bank, and Metal, with each seeing declines of two to three per cent.
Thu, Oct 24, 2024
The broader market displayed a mixed trend, with the BSE Midcap edging up 0.2 per cent while the BSE Smallcap stayed flat. as HUL tumbles 5%; financials, cement stocks cushion losses
Wed, Oct 23, 2024
The company's EBITDA margin for the quarter improved to 15.8 per cent, and cash flow from operations totalled 10.9 million dollars.
RITES shares surged nearly 3% after securing a Rs 454-crore contract from Karnataka Mining Corporation for railway infrastructure projects, boosting investor confidence despite a dip in Q1FY25 earnings.
Stocks to BUY for Long Term: Global sentiments are heavy on Indian stock markets and key benchmark indices opened on a negative note today i.e.
Mon, Oct 07, 2024
Garuda Construction and Engineering: Special discussion with top management on IPO, what is the future plan of the company?, how is the business model of the company?, what is the plan regarding capacity expansion?, what is the growth outlook for the future?, where will the IPO take place? Use of the money raised from?, watch AnilSinghvi's special conversation with the company's MD, Praveen Aggarwal.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
